| |
| |
|
| Insider
Information: |
Dubensky Thomas W. |
| Relationship: |
President, Director |
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
153,243 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,731,705 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
153,243 |
|
|
| Total
Value |
$1,731,705 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
Chief Scientific Officer |
2017-08-11 |
39,900 |
2015-11-16 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
President, Director |
2022-01-07 |
113,343 |
2021-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-11-16 |
4 |
OE |
$1.45 |
$13,747 |
D/D |
9,481 |
10,951 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-11-16 |
4 |
AS |
$27.50 |
$301,734 |
D/D |
(10,951) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-11-17 |
4 |
OE |
$1.45 |
$29,753 |
D/D |
20,519 |
20,519 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-11-17 |
4 |
AS |
$27.70 |
$587,822 |
D/D |
(20,519) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-12-01 |
4 |
OE |
$0.45 |
$64,373 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-12-01 |
4 |
AS |
$29.14 |
$878,104 |
D/D |
(30,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-01-04 |
4 |
AS |
$26.15 |
$395,531 |
D/D |
(15,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-01-04 |
4 |
OE |
$1.45 |
$70,158 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-05-16 |
4 |
AS |
$8.20 |
$7,421 |
D/D |
(905) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-07-05 |
4 |
OE |
$0.52 |
$25,963 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-07-05 |
4 |
AS |
$11.61 |
$290,250 |
D/D |
(25,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-08-11 |
4 |
AS |
$15.18 |
$379,500 |
D/D |
(25,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-08-11 |
4 |
OE |
$0.52 |
$24,625 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-09-01 |
4 |
OE |
$0.52 |
$28,259 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-09-01 |
4 |
AS |
$14.03 |
$350,775 |
D/D |
(25,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
39,900 |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-10-03 |
4 |
OE |
$0.52 |
$27,437 |
D/D |
25,000 |
64,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-10-03 |
4 |
AS |
$12.68 |
$316,908 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-11-10 |
4 |
AS |
$14.78 |
$369,408 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-11-10 |
4 |
OE |
$0.52 |
$32,588 |
D/D |
25,000 |
64,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
OE |
$0.52 |
$25,893 |
D/D |
25,000 |
64,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
AS |
$10.94 |
$273,500 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-01-03 |
4 |
OE |
$0.52 |
$13,000 |
D/D |
25,000 |
64,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-01-03 |
4 |
AS |
$11.16 |
$278,990 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-03-09 |
4 |
AS |
$10.96 |
$274,078 |
D/D |
(25,000) |
39,900 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
